Pharma Can Get SPCs For Multi-Ingredient Drugs, ECJ Rules
The European Union's top court has held that pharmaceutical companies can extend patent protections for drugs comprising two active ingredients, in a major ruling for branded drugmakers....To view the full article, register now.
Already a subscriber? Click here to view full article